DRTECH Corporation (KOSDAQ:214680)
South Korea · Delayed Price · Currency is KRW 3,915.00
0.00 (0.00%)
Oct 2, 2026, 3:30 PM KST
DRTECH Revenue
DRTECH had revenue of 37.00B KRW in the quarter ending June 30, 2026, with 10.29% growth. This brings the company's revenue in the last twelve months to 126.23B, up 11.84% year-over-year. In the year 2025, DRTECH had annual revenue of 116.30B with 19.21% growth.
Revenue (ttm)
126.23B
Revenue Growth
+11.84%
P/S Ratio
0.52
Revenue / Employee
347.75M
Employees
363
Market Cap
65.36B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 116.30B | 18.74B | 19.21% |
| Dec 31, 2024 | 97.56B | 5.12B | 5.54% |
| Dec 31, 2023 | 92.44B | 2.96B | 3.31% |
| Dec 31, 2022 | 89.48B | 19.20B | 27.33% |
| Dec 31, 2021 | 70.28B | 15.01B | 27.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ray Co., Ltd. | 119.17B |
| Osang Healthcare Co.,Ltd | 96.48B |
| LabGenomics | 77.64B |
| T&R Biofab | 32.73B |
| Humasis | 31.73B |
| Access Bio | 23.54B |
| Sugentech | 9.78B |
| P&S Robotics | 8.55B |